How Will You Talk to Patients About a COVID-19 Vaccine?

December 21, 2020

Soon after the US Food and Drug Administration authorized the Pfizer-BioNTech COVID-19 vaccine, a Centers for Disease Control and Prevention (CDC) advisory committee recommended the vaccine for people aged 16 years and older, stating they found it was safe and effective. Other countries, such as the United Kingdom, have begun vaccine rollout for a large number of at-risk populations and healthcare workers.

The CDC said it will quickly issue guidance to clinicians so they can determine when and when not to give the vaccine and to help them communicate the risks and benefits to patients.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.